Research progress on positron emission tomography using radionuclide-labeled fibroblast activation protein inhibitor in diagnosis of cardiac diseases
Fibroblast activation protein (FAP) is a type Ⅱ transmembrane serine protease specifically expressed on the surface of activated cardiac fibroblasts (CFs). During myocardial injury, inflammation, and fibrosis, it drives myocardial interstitial remodeling and collagen deposition by degrading the extr...
Saved in:
Main Author: | JIA Yingqi, ZHANG Min, LI Biao |
---|---|
Format: | Article |
Language: | Chinese |
Published: |
Editorial Office of Journal of Diagnostics Concepts & Practice
2025-04-01
|
Series: | Zhenduanxue lilun yu shijian |
Subjects: | |
Online Access: | https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1752188877346-1457288638.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of the cardiac extracellular matrix in the onset and progression of heart failure
by: N. N. Ilov, et al.
Published: (2021-07-01) -
Inhibitory effect of doxycycline on mmp2/9 and its improvement in cardiac function and left ventricular remodeling after myocardial infarction in rats
by: Fenli ZHANG, et al.
Published: (2025-05-01) -
Myocardial remodeling and fibroblast growth factor in patients with resistant hypertension
by: M. S. Litvinova, et al.
Published: (2022-12-01) -
Saliva-derived exosomes regulate fibroblast metabolic reprogramming in skin wound healing
by: Sijia Song, et al.
Published: (2025-07-01) -
Connective tissue and the problems of its pathological conditions
by: V. A. Shkurupy, et al.
Published: (2018-01-01)